Detalhe da pesquisa
1.
Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma.
J Nanobiotechnology
; 16(1): 47, 2018 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29720199
2.
Transfer of the human NKG2D ligands UL16 binding proteins (ULBP) 1-3 is related to lytic granule release and leads to ligand retransfer and killing of ULBP-recipient natural killer cells.
Immunology
; 146(1): 70-80, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25980678
3.
A GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA*008.
Biochem J
; 454(2): 295-302, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23772752
4.
SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors.
Cancer Discov
; 14(1): 120-141, 2024 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37934001
5.
Natural killer cell hyporesponsiveness and impaired development in a CD247-deficient patient.
J Allergy Clin Immunol
; 137(3): 942-5.e4, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26542031
6.
CyTOF analysis identifies unusual immune cells in urine of BCG-treated bladder cancer patients.
Front Immunol
; 13: 970931, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36189320
7.
Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses.
Elife
; 112022 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35904241
8.
An Immunocapture-Based Assay for Detecting Multiple Antigens in Melanoma-Derived Extracellular Vesicles.
Methods Mol Biol
; 2265: 323-344, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33704725
9.
BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine.
Cancers (Basel)
; 11(7)2019 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31277459
10.
Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors.
Oncoimmunology
; 7(2): e1392426, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29308322
11.
Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytes.
Oncoimmunology
; 6(4): e1293212, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28507799
12.
Glycosyl-Phosphatidyl-Inositol (GPI)-Anchors and Metalloproteases: Their Roles in the Regulation of Exosome Composition and NKG2D-Mediated Immune Recognition.
Front Cell Dev Biol
; 4: 97, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27672635
13.
Ionomycin Treatment Renders NK Cells Hyporesponsive.
PLoS One
; 11(3): e0150998, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27007115
14.
Development of a rapid lateral flow immunoassay test for detection of exosomes previously enriched from cell culture medium and body fluids.
J Extracell Vesicles
; 5: 31803, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27527605
15.
NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation.
Front Immunol
; 6: 284, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26106390